Your browser doesn't support javascript.
loading
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.
Sun, Roger; Sundahl, Nora; Hecht, Markus; Putz, Florian; Lancia, Andrea; Rouyar, Angela; Milic, Marina; Carré, Alexandre; Battistella, Enzo; Alvarez Andres, Emilie; Niyoteka, Stéphane; Romano, Edouard; Louvel, Guillaume; Durand-Labrunie, Jérôme; Bockel, Sophie; Bahleda, Rastilav; Robert, Charlotte; Boutros, Celine; Vakalopoulou, Maria; Paragios, Nikos; Frey, Benjamin; Soria, Jean-Charles; Massard, Christophe; Ferté, Charles; Fietkau, Rainer; Ost, Piet; Gaipl, Udo; Deutsch, Eric.
Afiliação
  • Sun R; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.
  • Sundahl N; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Hecht M; Paris-Saclay University Faculty of Medicine, Le Kremlin-Bicetre, Île-de-France, France.
  • Putz F; Department of Radiation Oncology, University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium.
  • Lancia A; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Rouyar A; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Milic M; Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy.
  • Carré A; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Battistella E; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Alvarez Andres E; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.
  • Niyoteka S; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Romano E; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Louvel G; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Durand-Labrunie J; TheraPanacea, Paris, France.
  • Bockel S; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Bahleda R; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.
  • Robert C; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.
  • Boutros C; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.
  • Vakalopoulou M; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.
  • Paragios N; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Frey B; Paris-Saclay University Faculty of Medicine, Le Kremlin-Bicetre, Île-de-France, France.
  • Soria JC; Drug Development Department, Gustave Roussy, Villejuif, Île-de-France, France.
  • Massard C; Department of Radiation Oncology, Gustave Roussy, Villejuif, Île-de-France, France.
  • Ferté C; Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay University, Villejuif, Île-de-France, France.
  • Fietkau R; Departement of Medicine, Gustave Roussy, Villejuif, Île-de-France, France.
  • Ost P; CentraleSupélec, Gif-sur-Yvette, Île-de-France, France.
  • Gaipl U; TheraPanacea, Paris, France.
  • Deutsch E; CentraleSupélec, Gif-sur-Yvette, Île-de-France, France.
J Immunother Cancer ; 8(2)2020 11.
Article em En | MEDLINE | ID: mdl-33188037
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) / Linfócitos T CD8-Positivos / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia (Especialidade) / Linfócitos T CD8-Positivos / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França